- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & Conditions
- •Privacy Policy
- •Copyright
© The Financial Times Ltd 2012 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
From
WORLD
10:58pm
May 15, 2012
Curb export of prescription drugs, MPs say
‘Speculators’ who sell medicines to other EU nations create shortages
From
UK
May 14, 2012
UK report clears breast implant regulator
British agency should have been more critical
From
HEALTH CARE
May 14, 2012
Bohuon clicks with Smith & Nephew
Experience was primarily in pharmaceuticals
May 14, 2012
Debate rages over HIV drug
Critics fear pre-emptive treatment will lift infection rates
- Pharmaceuticals Philanthropy and business join forces
- Editorial The Global Fund must come of age
Week in Review
May 11, 2012
Witty targets HGS with first hostile bid
GlaxoSmithKline chief still faces big tests for his leadership
May 11, 2012
Study setback weighs on Phytopharm
Pre-clinical results of glaucoma treatment disappoint
May 9, 2012
Teva sales disappoint on chief’s exit
Costs, exchange rates and European slowdown blamed
From
WORLD
May 9, 2012
Indian drug regulator accused of malpractice
Parliamentary report alleges collusion to approve medicines
- Pharma tries to avoid falling off ‘patent cliff’
- Letter from Lex Pharmachines
From
UK
May 8, 2012
Call to cut NHS price cap for new drugs
Findings to fuel debate with drugs companies
May 7, 2012
Abbott agrees $1.6bn Depakote settlement
Bipolar disorder drug allegedly marketed for unapproved uses
From
LEX
May 7, 2012
Cystic fibrosis drugs: strong combo
Vertex therapy could be multibillion-dollar product
May 7, 2012
Roche loses 3.45% after it abandons drug trial
Blow to efforts to diversify new medicine portfolio
May 6, 2012
Drugmakers see $33bn bout of M&A activity
Spate of takeovers makes pharma busiest sector
May 6, 2012
Generic rivals are also being blown off-course
Many off-patent counterparts also feeling pressure
Multimedia
Markets are following the patterns of 2010 and 2011 - but that doesn’t make 2012 Groundhog Year
VIDEO
Markets are following the patterns of 2010 and 2011 - but that doesn’t make 2012 Groundhog Year
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 Editor's Choice
In depth
Highlights
Most popular in Companies
exec-appointments.com
-
Chief Executive (Director General)
Office for National Statistics
-
Finance Expert
McKinsey & Company
-
Director of Organisational Capability and Performance
The Office for National Statistics
-
Head of Change Management
Argos
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- MBA Newslines
- Today's newspaper
- FT press cuttings
- FT ePaper
- Economic calendar
GSK’s knowledge key to hostility